Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Oncocyte Corp | Chief Financial Officer | Common Stock, no par value | 151K | $310K | $2.05 | Feb 7, 2025 | Direct |
Oncocyte Corp | Chief Financial Officer | Restricted Stock Units | 113K | $232K | $2.05 | Mar 26, 2025 | Direct |
Insight Molecular Diagnostics Inc. | Chief Financial Officer | Option to Purchase Common Stock | 235K | Sep 28, 2025 | Direct | ||
Oncocyte Corp | Chief Financial Officer | Options to Purchase Common Stock | 200K | Oct 11, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
IMDX | Insight Molecular Diagnostics Inc. | Sep 28, 2025 | 1 | $0 | 4 | Sep 30, 2025 | Chief Financial Officer |
OCX | Oncocyte Corp | Mar 26, 2025 | 1 | $0 | 4 | Mar 28, 2025 | Chief Financial Officer |
OCX | Oncocyte Corp | Feb 7, 2025 | 1 | $200K | 4 | Feb 11, 2025 | Chief Financial Officer |
OCX | Oncocyte Corp | Dec 5, 2024 | 1 | $45.8K | 4 | Dec 9, 2024 | Chief Financial Officer |
OCX | Oncocyte Corp | Oct 11, 2024 | 2 | $0 | 4 | Oct 15, 2024 | Chief Financial Officer |
OCX | Oncocyte Corp | Oct 2, 2024 | 1 | $100K | 4 | Oct 4, 2024 | Chief Financial Officer |
OCX | Oncocyte Corp | Jun 20, 2024 | 2 | $0 | 4 | Jun 24, 2024 | Chief Financial Officer |
OCX | Oncocyte Corp | Jun 17, 2024 | 0 | $0 | 3 | Jun 24, 2024 | Chief Financial Officer |